-+ 0.00%
-+ 0.00%
-+ 0.00%

Basilea Pharmaceutica Signs Partnership to Develop Antibiotics Using AI

MT Newswires·12/12/2025 00:11:51
Listen to the news
12:11 AM EST, 12/12/2025 (MT Newswires) -- Swiss biopharmaceutical company Basilea Pharmaceutica (BSLN.SW) agreed to partner with US-based Phare Bio for antibiotic discovery and development. Basilea said in a Thursday release that Phare will use its generative artificial intelligence platform to design and identify molecules for potential products. Basilea will be responsible for subsequent development, with Phare to receive success-based payments.